Purchases and Sales Made in Q4 2023 in Bluebird Bio, Inc. (BLUE)
This table provides information about the institutional ownership of Bluebird Bio, Inc. (BLUE) during Q4 2023. The information is specifically focused on institutions that hold shares of bluebird bio, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-1.11M- 60.09% |
$1.46M - $5.34M
|
735K
$272K
|
|
|
Feb 08, 2024
Q4 2023
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-1.71M- 96.04% |
$2.26M - $8.28M
|
70.6K
$26.1K
|
|
|
Feb 14, 2024
Q4 2023
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-2.23M- 81.67% |
$2.94M - $10.8M
|
500K
$185K
|
|
|
Feb 14, 2024
Q4 2023
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-4M- 66.19% |
$5.28M - $19.3M
|
2.04M
$756K
|
|
|
Feb 14, 2024
Q4 2023
|
Tang Capital Management LLC
San Diego, CA |
SELL
|
- |
-5.68M- 76.97% |
$7.5M - $27.4M
|
1.7M
$629K
|